Bone mineral density in systemic lupus erythematosus women one year after rituximab therapy.

about

Feasibility of measurement of bone turnover markers in female patients with systemic lupus erythematosus.Assessment of bone mineral density and bone metabolism in young male adults recently diagnosed with systemic lupus erythematosus in China.

P2860

Q51064096-7793CDCC-945A-4F93-84BA-A92A6CF4039D Q51471305-983A279C-49C4-407D-A946-3F21BC61D80D

P2860

Bone mineral density in systemic lupus erythematosus women one year after rituximab therapy.

Item

http://www.wikidata.org/entity/Q44794499

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Bone mineral density in system ...... year after rituximab therapy.

@en

Bone mineral density in system ...... year after rituximab therapy.

@nl

type

Item

label

Bone mineral density in system ...... year after rituximab therapy.

@en

Bone mineral density in system ...... year after rituximab therapy.

@nl

prefLabel

Bone mineral density in system ...... year after rituximab therapy.

@en

Bone mineral density in system ...... year after rituximab therapy.

@nl

P1476

Bone mineral density in system ...... year after rituximab therapy.

@en

P2093

A López Colombo

http://www.w3.org/2001/XMLSchema#string

A Montiel Jarquín

http://www.w3.org/2001/XMLSchema#string

A Rodríguez Gallegos

http://www.w3.org/2001/XMLSchema#string

C Jiménez Hernández

http://www.w3.org/2001/XMLSchema#string

C Mendoza Pinto

http://www.w3.org/2001/XMLSchema#string

G Ramos Alvarez

http://www.w3.org/2001/XMLSchema#string

I Etchegaray Morales

http://www.w3.org/2001/XMLSchema#string

M García Carrasco

http://www.w3.org/2001/XMLSchema#string

M Jiménez Hernández

http://www.w3.org/2001/XMLSchema#string

R Briones Rojas

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoimmunology: interactions of the bone and immune system

IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Loss of bone mineral density in premenopausal women with systemic lupus erythematosus

Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Risk factors of vertebral fractures in women with systemic lupus erythematosus.

Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha.

P304

1128-1134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203313502861

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ricard Cervera

P577

2013-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256290652

http://www.w3.org/2001/XMLSchema#string

P698

23989736

http://www.w3.org/2001/XMLSchema#string

Bone mineral density in systemic lupus erythematosus women one year after rituximab therapy.

about

P2860

P2860

Bone mineral density in systemic lupus erythematosus women one year after rituximab therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698